Citations (102)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Johanna Quick-Weller, Stephanie Lescher, Marie-Therese Forster, Jürgen Konczalla, Volker Seifert & Christian Senft. (2016) Combination of 5-ALA and iMRI in re-resection of recurrent glioblastoma. British Journal of Neurosurgery 30:3, pages 313-317.
Read now
Read now
Pasquale De Bonis, Francesco Doglietto, Carmelo Anile, Angelo Pompucci & Annunziato Mangiola. (2012) Electric fields for the treatment of glioblastoma. Expert Review of Neurotherapeutics 12:10, pages 1181-1184.
Read now
Read now
Carmen Balañá, Salvador Villá & Pilar Teixidor. (2011) Evolution of care for patients with relapsed glioblastoma. Expert Review of Anticancer Therapy 11:11, pages 1719-1729.
Read now
Read now
Melike Mut & David Schiff. (2009) Unmet needs in the treatment of glioblastoma. Expert Review of Anticancer Therapy 9:5, pages 545-551.
Read now
Read now
A. R. Brodbelt. (2008) Neuro-oncology and education. British Journal of Neurosurgery 22:3, pages 307-308.
Read now
Read now
Articles from other publishers (97)
Nisha V. Kalayil, Pallavi P. Paul, Showkhiya Y. Khan & Shona S. D'Souza. (2023) Advancing Glioblastoma Therapy: Promising Research in Precision
Medicine. Drug Delivery Letters 13:4, pages 264-282.
Crossref
Crossref
Andrew A. Hardigan, Joshua D. Jackson & Anoop P. Patel. (2023) Surgical Management and Advances in the Treatment of Glioma. Seminars in Neurology.
Crossref
Crossref
Mahsa Vaezzadeh, Ehsan Kachooei, Shivani Krishnamurthy, Preeti Manandhar, Annemarie Nadort, Gilles J Guillemin, Antonio Di Ieva, Marina Santiago, Benjamin Heng & Anna Guller. (2023) Combination Drug Therapy of Glioblastoma: Lessons from 3D In Vitro Models and the Roadmap for Future Research. Advanced Therapeutics 6:11.
Crossref
Crossref
Maysam Alimohamadi, Amirhossein Larijani, Ahmad Pour-Rashidi, Mostafa Farzin, Hannan Ebrahimi, Mohamad Rahmani, Kasra Hendi, Kourosh Karimi Yarandi, Sepehr Aghajanian & Mohammad Shirani. (2023) Comparative Analysis of the Prognostic Significance of IDH,TERT, EGFR and MGMT Status in Patients with Adult Non-H3-Altered Grade 4 Gliomas: A Prospective Cohort Study. World Neurosurgery.
Crossref
Crossref
Leszek Królicki, Jolanta Kunikowska, Frank Bruchertseifer, Radosław Kuliński, Dariusz Pawlak, Henryk Koziara, Rafał Rola, Alfred Morgenstern & Adrian Merlo. (2023) Locoregional Treatment of Glioblastoma With Targeted α Therapy. Clinical Nuclear Medicine 48:5, pages 387-392.
Crossref
Crossref
A.J. Vargas López, C. Fernández Carballal, M. Valera Melé & G. Rodríguez-Boto. (2023) Survival analysis in high-grade glioma: The role of salvage surgery. Neurología (English Edition) 38:1, pages 21-28.
Crossref
Crossref
A.J. Vargas López, C. Fernández Carballal, M. Valera Melé & G. Rodríguez-Boto. (2023) Análisis de supervivencia en gliomas de alto grado: papel de la cirugía de rescate. Neurología 38:1, pages 22-29.
Crossref
Crossref
Víctor González, Marta Brell, José Fuster, Lesmes Moratinos, Daniel Alegre, Sofía López & Javier Ibáñez. (2022) Analyzing the role of reoperation in recurrent glioblastoma: a 15-year retrospective study in a single institution. World Journal of Surgical Oncology 20:1.
Crossref
Crossref
Patrizia Ciammella, Salvatore Cozzi, Andrea Botti, Lucia Giaccherini, Roberto Sghedoni, Matteo Orlandi, Manuela Napoli, Rosario Pascarella, Anna Pisanello, Marco Russo, Francesco Cavallieri, Maria Paola Ruggieri, Silvio Cavuto, Luisa Savoldi, Cinzia Iotti & Mauro Iori. (2022) Safety of Inhomogeneous Dose Distribution IMRT for High-Grade Glioma Reirradiation: A Prospective Phase I/II Trial (GLIORAD TRIAL). Cancers 14:19, pages 4604.
Crossref
Crossref
Augusto Leone, Antonio Colamaria, Nicola Pio Fochi, Matteo Sacco, Matteo Landriscina, Giovanni Parbonetti, Matteo de Notaris, Giulia Coppola, Elena De Santis, Guido Giordano & Francesco Carbone. (2022) Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era. Biomedicines 10:8, pages 1927.
Crossref
Crossref
Jacek Furtak, Artur Kwiatkowski, Paulina Śledzińska, Marek Bebyn, Stanisław Krajewski, Tadeusz Szylberg, Marcin Birski, Adam Druszcz, Kamil Krystkiewicz, Piotr Gasiński & Marek Harat. (2022) Survival after reoperation for recurrent glioblastoma multiforme: A prospective study. Surgical Oncology 42, pages 101771.
Crossref
Crossref
Mattia Russel Pantalone, Afsar Rahbar, Cecilia Söderberg-Naucler & Giuseppe Stragliotto. (2022) Valganciclovir as Add-on to Second-Line Therapy in Patients with Recurrent Glioblastoma. Cancers 14:8, pages 1958.
Crossref
Crossref
M. Patel, K. Au, J.C. Easaw, F.G. Davis, K. Young, V. Mehta, G.N. Bowden, M.B. Keough, T. Sankar, F. Scholtes, M. Chagnon, G. L’Espérance, Y. Yuan, G. Gevry, J. Raymond & T.E. Darsaut. (2022) Repeat resection in recurrent glioblastoma (3rGBM) Trial: A randomized care trial. Neurochirurgie 68:3, pages 262-266.
Crossref
Crossref
Kaiyun Yang, Yosef Ellenbogen, Amanda Martyniuk, Michel Sourour, Radwan Takroni, Mohamed Somji, Emily Gardiner, Katrina Hui, Devang Odedra, Ramiro Larrazabal, Almunder Algird, Edward Kachur, Kesava Reddy, Naresh Murty, Forough Farrokhyar & Sheila K Singh. (2022) Reoperation in adult patients with recurrent glioblastoma: A matched cohort analysis. Neuro-Oncology Advances 4:1.
Crossref
Crossref
Cassandra P Griffin, Christine L Paul, Kimberley L Alexander, Marjorie M Walker, Hubert Hondermarck & James Lynam. (2022) Postmortem brain donations vs premortem surgical resections for glioblastoma research: viewing the matter as a whole. Neuro-Oncology Advances 4:1.
Crossref
Crossref
L. Krolicki, J. Kunikowska, F. Bruchertseifer, H. Koziara, A. Morgenstern, B. Krolicki, E. Rosiak, D. Pawlak & A. Merlo. 2022. Nuclear Medicine and Molecular Imaging. Nuclear Medicine and Molecular Imaging
1
16
.
Yun Guan, Ji Xiong, Mingyuan Pan, Wenyin Shi, Jing Li, Huaguang Zhu, Xiu Gong, Chao Li, Guanghai Mei, Xiaoxia Liu, Li Pan, Jiazhong Dai, Yang Wang, Enmin Wang & Xin Wang. (2021) Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience. BMC Cancer 21:1.
Crossref
Crossref
Eliot Fletcher-Sananikone, Suman Kanji, Nozomi Tomimatsu, Luis Fernando Macedo Di Cristofaro, Rahul K. Kollipara, Debabrata Saha, John R. Floyd, Patrick Sung, Robert Hromas, Terry C. Burns, Ralf Kittler, Amyn A. Habib, Bipasha Mukherjee & Sandeep Burma. (2021) Elimination of Radiation-Induced Senescence in the Brain Tumor Microenvironment Attenuates Glioblastoma Recurrence. Cancer Research 81:23, pages 5935-5947.
Crossref
Crossref
Leszek Królicki, Frank Bruchertseifer, Jolanta Kunikowska, Henryk Koziara, Dariusz Pawlak, Radosław Kuliński, Rafał Rola, Adrian Merlo & Alfred Morgenstern. (2021) Dose escalation study of targeted alpha therapy with [225Ac]Ac-DOTA-substance P in recurrence glioblastoma – safety and efficacy. European Journal of Nuclear Medicine and Molecular Imaging 48:11, pages 3595-3605.
Crossref
Crossref
P. M. Brennan, R. Borchert, C. Coulter, G. R. Critchley, B. Hall, D. Holliman, I. Phang, S. J. Jefferies, S. Keni, L. Lee, I. Liaquat, H. J. Marcus, S. Thomson, L. Thorne, M. Vintu, A. N. Wiggins, M. D. Jenkinson & S. Erridge. (2021) Second surgery for progressive glioblastoma: a multi‐centre questionnaire and cohort‐based review of clinical decision‐making and patient outcomes in current practice. Journal of Neuro-Oncology 153:1, pages 99-107.
Crossref
Crossref
Lucio De Maria, Lodovico Terzi di Bergamo, Alfredo Conti, Kazuhiko Hayashi, Valentina Pinzi, Taro Murai, Rachelle Lanciano, Sigita Burneikiene, Michela Buglione di Monale, Stefano Maria Magrini & Marco Maria Fontanella. (2021) CyberKnife for Recurrent Malignant Gliomas: A Systematic Review and Meta-Analysis. Frontiers in Oncology 11.
Crossref
Crossref
Giuseppe Maria Vincenzo Barbagallo, Francesco Certo, Stefania Di GregorioMassimiliano MaioneMarco GarozzoSimone PeschilloRoberto Altieri. (2021) Recurrent high-grade glioma surgery: a multimodal intraoperative protocol to safely increase extent of tumor resection and analysis of its impact on patient outcome. Neurosurgical Focus 50:1, pages E20.
Crossref
Crossref
Shigeru YAMAGUCHI, Hiroaki MOTEGI, Yukitomo ISHI, Michinari OKAMOTO, Ryosuke SAWAYA, Hiroyuki KOBAYASHI, Shunsuke TERASAKA & Kiyohiro HOUKIN. (2021) Clinical Outcome of Cytoreductive Surgery Prior to Bevacizumab for Patients with Recurrent Glioblastoma: A Single-center Retrospective Analysis. Neurologia medico-chirurgica 61:4, pages 245-252.
Crossref
Crossref
Rasheed Zakaria & Jeffrey S. Weinberg. (2021) Challenges Associated with Reoperation in Patients with Glioma. Neurosurgery Clinics of North America 32:1, pages 129-135.
Crossref
Crossref
Cristina Birzu, Pim French, Mario Caccese, Giulia Cerretti, Ahmed Idbaih, Vittorina Zagonel & Giuseppe Lombardi. (2020) Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives. Cancers 13:1, pages 47.
Crossref
Crossref
Elmira Mohtashami, Negar Shafaei-Bajestani, Hamid Mollazadeh, Seyed Hadi Mousavi, Mohammad Jalili-Nik, Amirhossein Sahebkar & Amir R. Afshari. (2020) The Current State of Potential Therapeutic Modalities for Glioblastoma Multiforme: A Clinical Review. Current Drug Metabolism 21:8, pages 564-578.
Crossref
Crossref
Joshua Giambattista, Egiroh Omene, Osama Souied & Fred H.C. Hsu. (2020) Modern Treatments for Gliomas Improve Outcome. Current Cancer Therapy Reviews 16:3, pages 221-245.
Crossref
Crossref
Senne Broekx, Frank Weyns & Steven De Vleeschouwer. (2020) 5-Aminolevulinic acid for recurrent malignant gliomas: A systematic review. Clinical Neurology and Neurosurgery 195, pages 105913.
Crossref
Crossref
Vilashini Rajaratnam, Mohammad Islam, Maixee Yang, Rachel Slaby, Hilda Ramirez & Shama Mirza. (2020) Glioblastoma: Pathogenesis and Current Status of Chemotherapy and Other Novel Treatments. Cancers 12:4, pages 937.
Crossref
Crossref
Leszek Królicki, Jolanta Kunikowska, Frank Bruchertseifer, Henryk Koziara, Bartosz Królicki, Maciej Jakuciński, Dariusz Pawlak, Rafał Rola, Alfred Morgenstern, Elżbieta Rosiak & Adrian Merlo. (2020) 225Ac- and 213Bi-Substance P Analogues for Glioma Therapy. Seminars in Nuclear Medicine 50:2, pages 141-151.
Crossref
Crossref
Francesco Certo, Walter Stummer, Jibril O. Farah, Christian Freyschlag, Massimiliano Visocchi, Antonio Morrone, Roberto Altieri, Giada Toccaceli, Simone Peschillo, Claudius Thomè, Michael Jenkinson & Giuseppe Barbagallo. (2020) Supramarginal resection of glioblastoma: 5-ALA fluorescence, combined intraoperative strategies and correlation with survival. Journal of Neurosurgical Sciences 63:6.
Crossref
Crossref
Soumya Mukherjee, Joseph Wood, Imran Liaquat, Simon R. Stapleton & Andrew J. Martin. (2020) Craniotomy for recurrent glioblastoma: Is it justified? A comparative cohort study with outcomes over 10 years. Clinical Neurology and Neurosurgery 188, pages 105568.
Crossref
Crossref
Yahia-Cherif Djamel-Eddine, Olivier De Witte, Christian Mélot & Florence Lefranc. (2019) Recurrent glioblastomas: Should we operate a second and even a third time?. Interdisciplinary Neurosurgery 18, pages 100551.
Crossref
Crossref
Yan-jia Hu, Da Chen, Li-feng Zhang & Jing Chen. (2019) Efficacy and Safety of Hypofractionated Stereotactic Radiotherapy for Recurrent Malignant Gliomas: A Systematic Review and Meta-analysis. World Neurosurgery 127, pages 176-185.
Crossref
Crossref
Leszek Królicki, Frank Bruchertseifer, Jolanta Kunikowska, Henryk Koziara, Bartosz Królicki, Maciej Jakuciński, Dariusz Pawlak, Christos Apostolidis, Saed Mirzadeh, Rafał Rola, Adrian Merlo & Alfred Morgenstern. (2018) Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma. European Journal of Nuclear Medicine and Molecular Imaging 46:3, pages 614-622.
Crossref
Crossref
Victor M. Lu, Toni R. Jue, Kerrie L. McDonald & Richard A. Rovin. (2018) The Survival Effect of Repeat Surgery at Glioblastoma Recurrence and its Trend: A Systematic Review and Meta-Analysis. World Neurosurgery 115, pages 453-459.e3.
Crossref
Crossref
Nico Sollmann, Tobias Laub, Anna Kelm, Lucia Albers, Jan S Kirschke, Stephanie E Combs, Bernhard Meyer & Sandro M Krieg. (2018) Predicting brain tumor regrowth in relation to motor areas by functional brain mapping. Neuro-Oncology Practice 5:2, pages 82-95.
Crossref
Crossref
Yi-Ren Chen, Jon Sole, Beatrice Ugiliweneza, Eli Johnson, Eric Burton, Shiao Y. Woo, Maria Koutourousiou, Brian Williams, Maxwell Boakye & Stephen Skirboll. (2018) National Trends for Reoperation in Older Patients with Glioblastoma. World Neurosurgery 113, pages e179-e189.
Crossref
Crossref
Etienne Audureau, Anaïs Chivet, Renata Ursu, Robert Corns, Philippe Metellus, Georges Noel, Sonia Zouaoui, Jacques Guyotat, Pierre-Jean Le Reste, Thierry Faillot, Fabien Litre, Nicolas Desse, Antoine Petit, Evelyne Emery, Emmanuelle Lechapt-Zalcman, Johann Peltier, Julien Duntze, Edouard Dezamis, Jimmy Voirin, Philippe Menei, François Caire, Phong Dam Hieu, Jean-Luc Barat, Olivier Langlois, Jean-Rodolphe Vignes, Pascale Fabbro-Peray, Adeline Riondel, Elodie Sorbets, Marc Zanello, Alexandre Roux, Antoine Carpentier, Luc Bauchet & Johan Pallud. (2017) Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model. Journal of Neuro-Oncology 136:3, pages 565-576.
Crossref
Crossref
Jeongshim Lee, Sung Soo AhnJong Hee Chang & Chang-Ok Suh. (2018) Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival. Yonsei Medical Journal 59:2, pages 194.
Crossref
Crossref
Michael J. Gigliotti, Shaakir Hasan, Stephen M. Karlovits, Tulika Ranjan & Rodney E. Wegner. (2018) Re-Irradiation with Stereotactic Radiosurgery/Radiotherapy for Recurrent High-Grade Gliomas: Improved Survival in the Modern Era. Stereotactic and Functional Neurosurgery 96:5, pages 289-295.
Crossref
Crossref
J. Attal, L. Chaltiel, V. Lubrano, J. C. Sol, C. Lanaspeze, L. Vieillevigne, I. Latorzeff & E. Cohen-Jonathan Moyal. (2017) Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation. Journal of Neuro-Oncology 136:2, pages 413-419.
Crossref
Crossref
Jolanta Kunikowska, Alfred Morgenstern, Frank Bruchertseifer & Leszek Krolicki. 2018. Clinical Applications of Nuclear Medicine Targeted Therapy. Clinical Applications of Nuclear Medicine Targeted Therapy
465
473
.
Juan Delgado-Fernandez, Maria Ángeles Garcia-Pallero, Guillermo Blasco, Juan R. Penanes, Ricardo Gil-Simoes, Paloma Pulido & Rafael G. Sola. (2017) Usefulness of Reintervention in Recurrent Glioblastoma: An Indispensable Weapon for Increasing Survival. World Neurosurgery 108, pages 610-617.
Crossref
Crossref
JOOST DEJAEGHER & STEVEN DE VLEESCHOUWER. 2017. Glioblastoma. Glioblastoma
281
296
.
K. Zwirner, F. Paulsen, J. Schittenhelm, C. Borchers, M. Skardelly, D. Zips & F. Eckert. (2017) Prognostic parameters and outcome after re-irradiation for progressive glioblastoma. Acta Neurologica Scandinavica 136:3, pages 239-245.
Crossref
Crossref
Adam M. Robin, Ian Lee & Steven N. Kalkanis. (2017) Reoperation for Recurrent Glioblastoma Multiforme. Neurosurgery Clinics of North America 28:3, pages 407-428.
Crossref
Crossref
M. Azoulay, F. Santos, G. Shenouda, K. Petrecca, A. Oweida, M. C. Guiot, S. Owen, V. Panet-Raymond, L. Souhami & Bassam S. Abdulkarim. (2017) Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution. Journal of Neuro-Oncology 132:3, pages 419-426.
Crossref
Crossref
Harjus S Birk, Seunggu J Han & Nicholas A Butowski. (2017) Treatment options for recurrent high-grade gliomas. CNS Oncology 6:1, pages 61-70.
Crossref
Crossref
Federico Pessina, Pierina Navarria, Luca Cozzi, Stefano Tomatis, Marco Riva, Anna Maria Ascolese, Armando Santoro, Matteo Simonelli, Lorenzo Bello & Marta Scorsetti. (2016) Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study. Journal of Neuro-Oncology 131:2, pages 377-384.
Crossref
Crossref
Willey Gonçalves Zanovello, Suzana M. F. Malheiros, João Norberto Stavale, Orestes P. Lanzoni, Miguel M. Canteras, Adrialdo J. Santos, Felipe Slaviero, Bruno Fernandes, Sergio Cavalheiro & Manoel A. de Paiva Neto. (2016) Performance of adjuvant treatment correlates with survival in reoperated glioblastomas. Arquivos de Neuro-Psiquiatria 74:11, pages 887-894.
Crossref
Crossref
Patrick A. Tully, Andrew J. Gogos, Craig Love, Danny Liew, Katharine J. Drummond & Andrew P. Morokoff. (2016) Reoperation for Recurrent Glioblastoma and Its Association With Survival Benefit. Neurosurgery 79:5, pages 678-689.
Crossref
Crossref
Danilo Silva, Mayur Sharma & Gene H. Barnett. (2016) Laser Ablation vs Open Resection for Deep-Seated Tumors. Neurosurgery 63:Supplement 1, pages 15-26.
Crossref
Crossref
Oguz Ozel, Mehmet Kurt, Oguzhan Ozdemir, Jale Bayram, Huseyin Akdeniz & Dogan Koca. (2016) Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature review. Journal of Oncological Sciences 2:2-3, pages 87-94.
Crossref
Crossref
Amir Zolal, Tareq A. Juratli, Jennifer Linn, Dino Podlesek, Kerim Hakan Sitoci Ficici, Hagen H. Kitzler, Gabriele Schackert, Stephan B. Sobottka, Bernhard Rieger & Dietmar Krex. (2016) Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery. Journal of Neuro-Oncology 127:3, pages 551-557.
Crossref
Crossref
Min Wei Chen, Ahmed A. Morsy, Sai Liang & Wai Hoe Ng. (2016) Re-do Craniotomy for Recurrent Grade IV Glioblastomas: Impact and Outcomes from the National Neuroscience Institute Singapore. World Neurosurgery 87, pages 439-445.
Crossref
Crossref
Katharina Seystahl, Wolfgang Wick & Michael Weller. (2016) Therapeutic options in recurrent glioblastoma—An update. Critical Reviews in Oncology/Hematology 99, pages 389-408.
Crossref
Crossref
Alicia Ortega, J. Manuel Sarmiento, Diana Ly, Miriam Nuño, Debraj Mukherjee, Keith L. Black & Chirag G. Patil. (2016) Multiple resections and survival of recurrent glioblastoma patients in the temozolomide era. Journal of Clinical Neuroscience 24, pages 105-111.
Crossref
Crossref
Pierina Navarria, Anna Maria Ascolese, Stefano Tomatis, Giacomo Reggiori, Elena Clerici, Elisa Villa, Giulia Maggi, Lorenzo Bello, Federico Pessina, Luca Cozzi & Marta Scorsetti. (2016) Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge. Cancer Research and Treatment 48:1, pages 37-44.
Crossref
Crossref
Danilo Silva, Mayur Sharma, Telmo Belsuzarri & Gene H. Barnett. 2016. Glioblastoma. Glioblastoma
197
205
.
Silvia Chiesa, Mario Balducci, Milena Ferro, Anna Rita Alitto & Vincenzo Valentini. 2016. Radiobiology of Glioblastoma. Radiobiology of Glioblastoma
41
62
.
Christopher Dardis, Lynn Ashby, William Shapiro & Nader Sanai. (2015) Biopsy vs. extensive resection for first recurrence of glioblastoma: is a prospective clinical trial warranted?. BMC Research Notes 8:1.
Crossref
Crossref
Marta Scorsetti, Pierina Navarria, Federico Pessina, Anna Maria Ascolese, Giuseppe D’Agostino, Stefano Tomatis, Fiorenza De Rose, Elisa Villa, Giulia Maggi, Matteo Simonelli, Elena Clerici, Riccardo Soffietti, Armando Santoro, Luca Cozzi & Lorenzo Bello. (2015) Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma. BMC Cancer 15:1.
Crossref
Crossref
Randy S. D’Amico, Michael B. Cloney, Adam M. Sonabend, Brad Zacharia, Matthew N. Nazarian, Fabio M. Iwamoto, Michael B. Sisti, Jeffrey N. Bruce & Guy M. McKhannIIII. (2015) The Safety of Surgery in Elderly Patients with Primary and Recurrent Glioblastoma. World Neurosurgery 84:4, pages 913-919.
Crossref
Crossref
Joshua D. Palmer, Joshua Siglin, Kosj Yamoah, Tu Dan, Colin E. Champ, Voichita Bar-Ad, Maria Werner-Wasik, James J. Evans, Lyndon Kim, Jon Glass, Christopher Farrell, David W. Andrews & Wenyin Shi. (2015) Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better. Journal of Neuro-Oncology 124:2, pages 215-221.
Crossref
Crossref
Christoph Michael Woernle, Dominik Péus, Silvia Hofer, Elisabeth Jane Rushing, Ulrike Held, Oliver Bozinov, Niklaus Krayenbühl, Michael Weller & Luca Regli. (2015) Efficacy of Surgery and Further Treatment of Progressive Glioblastoma. World Neurosurgery 84:2, pages 301-307.
Crossref
Crossref
Shaakir Hasan, Eda Chen, Rachelle Lanciano, Jun Yang, Alex Hanlon, John Lamond, Stephen Arrigo, William Ding, Michael Mikhail, Arezoo Ghaneie & Luther Brady. (2015) Salvage Fractionated Stereotactic Radiotherapy with or without Chemotherapy and Immunotherapy for Recurrent Glioblastoma Multiforme: A Single Institution Experience. Frontiers in Oncology 5.
Crossref
Crossref
Ferrat Dincoglan, Murat Beyzadeoglu, Omer Sager, Selcuk Demiral, Hakan Gamsiz, Bora Uysal, Cuneyt Ebruli, Mustafa Akin, Kaan Oysul, Sait Sirin & Bahar Dirican. (2015) Management of Patients with Recurrent Glioblastoma using Hypofractionated Stereotactic Radiotherapy. Tumori Journal 101:2, pages 179-184.
Crossref
Crossref
Daniela Alexandru Abrams, Joseph A. Hanson, Justin M. Brown, Frank P.K. Hsu, Johnny B. DelashawJr.Jr. & Daniela A. Bota. (2015) Timing of surgery and bevacizumab therapy in neurosurgical patients with recurrent high grade glioma. Journal of Clinical Neuroscience 22:1, pages 35-39.
Crossref
Crossref
C. Watts, S.J. Price & T. Santarius. (2014) Current Concepts in the Surgical Management of Glioma Patients. Clinical Oncology 26:7, pages 385-394.
Crossref
Crossref
F. Nava, I. Tramacere, A. Fittipaldo, M. G. Bruzzone, F. DiMeco, L. Fariselli, G. Finocchiaro, B. Pollo, A. Salmaggi, A. Silvani, M. Farinotti & G. Filippini. (2014) Survival effect of first- and second-line treatments for patients with primary glioblastoma: a cohort study from a prospective registry, 1997-2010. Neuro-Oncology 16:5, pages 719-727.
Crossref
Crossref
Johanna Quick, Florian Gessler, Stephan Dützmann, Elke Hattingen, Patrick N. Harter, Lutz M. Weise, Kea Franz, Volker Seifert & Christian Senft. (2014) Benefit of tumor resection for recurrent glioblastoma. Journal of Neuro-Oncology 117:2, pages 365-372.
Crossref
Crossref
Patrizia Ciammella, Ala Podgornii, Maria Galeandro, Nunziata D’Abbiero, Anna Pisanello, Andrea Botti, Elisabetta Cagni, Mauro Iori & Cinzia Iotti. (2013) Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience. Radiation Oncology 8:1.
Crossref
Crossref
Signe Regner Michaelsen, Ib Jarle Christensen, Kirsten Grunnet, Marie-Thérése Stockhausen, Helle Broholm, Michael Kosteljanetz & Hans Skovgaard Poulsen. (2013) Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution. BMC Cancer 13:1.
Crossref
Crossref
Y. Sia, K. Field, M. Rosenthal & K. Drummond. (2013) Socio-demographic factors and their impact on the number of resections for patients with recurrent glioblastoma. Journal of Clinical Neuroscience 20:10, pages 1362-1365.
Crossref
Crossref
Tareq A Juratli, Gabriele Schackert & Dietmar Krex. (2013) Current status of local therapy in malignant gliomas — A clinical review of three selected approaches. Pharmacology & Therapeutics 139:3, pages 341-358.
Crossref
Crossref
Pasquale De Bonis, Alba Fiorentino, Carmelo Anile, Mario Balducci, Angelo Pompucci, Silvia Chiesa, Gigliola Sica, Gina Lama, Giulio Maira & Annunziato Mangiola. (2013) The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma. Clinical Neurology and Neurosurgery 115:7, pages 883-886.
Crossref
Crossref
Ammar Shaikhouni & E. Antonio Chiocca. (2013) Editorial: Glioblastoma and surgery. Journal of Neurosurgery 118:4, pages 809-811.
Crossref
Crossref
Michael Weller, Timothy Cloughesy, James R. Perry & Wolfgang Wick. (2013) Standards of care for treatment of recurrent glioblastoma—are we there yet?. Neuro-Oncology 15:1, pages 4-27.
Crossref
Crossref
Bente Sandvei Skeie, Per Øyvind Enger, Jan Brøgger, Jeremy Christopher Ganz, Frits Thorsen, Jan Ingeman Heggdal & Paal-Henning Pedersen. (2012) Gamma Knife Surgery versus Reoperation for Recurrent Glioblastoma Multiforme. World Neurosurgery 78:6, pages 658-669.
Crossref
Crossref
Colin Watts. (2012) Surgical management of high-grade glioma: a standard of care. CNS Oncology 1:2, pages 181-192.
Crossref
Crossref
Stephan Dützmann, Florian Geßler, Andrea Bink, Johanna Quick, Kea Franz, Volker Seifert & Christian Senft. (2012) Risk of ischemia in glioma surgery: comparison of first and repeat procedures. Journal of Neuro-Oncology 107:3, pages 599-607.
Crossref
Crossref
Thomas Wirth, Jere Tuomas Pikkarainen, Haritha Dhammika Samaranayake, Pauliina Lehtolainen‐Dalkilic, Hanna Pirita Lesch, Kari Juhani Airenne, Varpu Marjomäki & Seppo Pasi Antero Ylä‐Herttuala. (2012) Efficient gene therapy based targeting system for the treatment of inoperable tumors. The Journal of Gene Medicine 14:4, pages 221-230.
Crossref
Crossref
Dante Amelio & Maurizio Amichetti. (2012) Radiation Therapy for the Treatment of Recurrent Glioblastoma: An Overview. Cancers 4:1, pages 257-280.
Crossref
Crossref
Aaron J. Clark, Kathleen R. Lamborn, Nicholas A. Butowski, Susan M. Chang, Michael D. Prados, Jennifer L. Clarke, Michael W. McDermott, Andrew T. Parsa, Mitchel S. Berger & Manish K. Aghi. (2012) Neurosurgical Management and Prognosis of Patients With Glioblastoma That Progresses During Bevacizumab Treatment. Neurosurgery 70:2, pages 361-370.
Crossref
Crossref
Gregorio Catalán-Uribarrena, Gaizka Bilbao-Barandica, Iñigo Pomposo-Gaztelu, José Undabeitia-Huertas, Edurne Ruiz de Gopegui-Ruiz, Lara Galbarriatu-Gutiérrez, Manuel Canales-Llantada, Jon Aurrecoechea-Obieta, Alfonso Igartua-Azkune & Guillermo Carbayo-Lozano. (2011) Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis. Acta Neurochirurgica 154:2, pages 211-222.
Crossref
Crossref
Alfredo Conti, Antonio Pontoriero, Donatella Arpa, Carmelo Siragusa, Chiara Tomasello, Pantaleo Romanelli, Salvatore Cardali, Francesca Granata, Costantino De Renzis & Francesco Tomasello. (2011) Efficacy and toxicity of CyberKnife re-irradiation and “dose dense” temozolomide for recurrent gliomas. Acta Neurochirurgica 154:2, pages 203-209.
Crossref
Crossref
Xun Xu, Florian Stockhammer & Michael Schmitt. (2012) Cellular-Based Immunotherapies for Patients with Glioblastoma Multiforme. Clinical and Developmental Immunology 2012, pages 1-15.
Crossref
Crossref
Maurizio Amichetti & Dante Amelio. (2011) A Review of the Role of Re-Irradiation in Recurrent High-Grade Glioma (HGG). Cancers 3:4, pages 4061-4089.
Crossref
Crossref
Robert E. Elliott, Erik C. Parker, Stephen C. Rush, Stephen P. Kalhorn, Yaron A. Moshel, Ashwatha Narayana, Bernadine Donahue & John G. Golfinos. (2011) Efficacy of Gamma Knife Radiosurgery for Small-Volume Recurrent Malignant Gliomas After Initial Radical Resection. World Neurosurgery 76:1-2, pages 128-140.
Crossref
Crossref
Y. Li, J. M. Lupo, M.-Y. Polley, J. C. Crane, W. Bian, S. Cha, S. Chang & S. J. Nelson. (2011) Serial analysis of imaging parameters in patients with newly diagnosed glioblastoma multiforme. Neuro-Oncology 13:5, pages 546-557.
Crossref
Crossref
Abhirami VivekanandarajahBalakumar KrishnarasaMervat MouradNelly AounMarcel Odaimi. (2011) Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A case Report. Clinical Medicine Insights: Oncology 5, pages CMO.S6525.
Crossref
Crossref
Maximilian Niyazi, Axel Siefert, Silke Birgit Schwarz, Ute Ganswindt, Friedrich-Wilhelm Kreth, Jörg-Christian Tonn & Claus Belka. (2011) Therapeutic options for recurrent malignant glioma. Radiotherapy and Oncology 98:1, pages 1-14.
Crossref
Crossref
Herwig Kostron & Richard Bauer. (2011) Management of recurrent malignant glioma – neurosurgical strategiesManagement der rezivierten malignen Gliome – neurochirurgische Strategien. Wiener Medizinische Wochenschrift 161:1-2, pages 20-21.
Crossref
Crossref
R. Helseth, E. Helseth, T. B. Johannesen, C. W. Langberg, K. Lote, P. Rønning, D. Scheie, A. Vik & T. R. Meling. (2010) Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme. Acta Neurologica Scandinavica 122:3, pages 159-167.
Crossref
Crossref
Marcel Seiz, Ingo Nölte, Ioannis Pechlivanis, Christian F. Freyschlag, Kirsten Schmieder, Peter Vajkoczy & Jochen Tuettenberg. (2010) Far-distant metastases along the CSF pathway of glioblastoma multiforme during continuous low-dose chemotherapy with temozolomide and celecoxib. Neurosurgical Review 33:3, pages 375-381.
Crossref
Crossref
Pantaleo RomanelliAlfredo Conti, Antonio Pontoriero, Giuseppe Kenneth Ricciardi, Francesco Tomasello, Costantino De Renzis, Gualtiero InnocenziVincenzo EspositoGiampaolo Cantore. (2009) Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of recurrent glioblastoma multiforme. Neurosurgical Focus 27:6, pages E8.
Crossref
Crossref